113 related articles for article (PubMed ID: 1438437)
1. Immunomagnetic depletion of CD8+ lymphocytes from marrow grafts.
Jansen J; Hanks S; English D; Karaffa R; Akard L
Prog Clin Biol Res; 1992; 377():405-10. PubMed ID: 1438437
[No Abstract] [Full Text] [Related]
2. The combined use of elutriation and CD8/magnetic bead separation to engineer the bone marrow allograft.
Noga SJ; Davis JM; Vogelsang GB; Donnenberg AD; Thoburn C; Schepers K; Sproul J
Prog Clin Biol Res; 1992; 377():411-8. PubMed ID: 1438439
[No Abstract] [Full Text] [Related]
3. Selective depletion of CD8-positive T-lymphocytes for allogeneic bone marrow transplantation: engraftment, graft-versus-host disease and graft-versus leukemia.
Champlin R; Giralt S; Przepiorka D; Ho W; Lee K; Gajewski J; Nimer S; Andersson B; Wallerstein R; Ippolito C
Prog Clin Biol Res; 1992; 377():385-94; discussion 395-8. PubMed ID: 1438435
[No Abstract] [Full Text] [Related]
4. Use of a closed system for V alpha beta-positive T cell depletion of marrow for use in partially mismatched related donor (PMRD) transplantation.
Lee C; Brouillette M; Lamb L; Pati A; Brown S; Thompson J; Parrish R; Henslee-Downey PJ; Gee AP
Prog Clin Biol Res; 1994; 389():523-32. PubMed ID: 7700917
[No Abstract] [Full Text] [Related]
5. Prevention of graft-versus-host disease by using immunotoxins.
Laurent G; Bouloux C
Prog Clin Biol Res; 1992; 377():129-36; discussion 137. PubMed ID: 1438408
[No Abstract] [Full Text] [Related]
6. New technology for the depletion of T cells from soybean lectin agglutinated, HLA-matched bone marrow grafts for leukemia: initial laboratory and clinical results.
Collins NH; Carabasi MH; Bleau S; Jagiello C; Young JW; Castro-Malaspina H; Flomenberg N; Papadopoulos EB; Emanuel D; Gillio A
Prog Clin Biol Res; 1992; 377():427-39. PubMed ID: 1438441
[No Abstract] [Full Text] [Related]
7. Immunomagnetic CD8 depletion.
Jansen J; Hanks S; Akard L; Martin M; Ash R; Thompson J; English D
Prog Clin Biol Res; 1994; 389():551-6. PubMed ID: 7700920
[No Abstract] [Full Text] [Related]
8. Selective depletion of CD8 positive T-lymphocytes for prevention of graft-versus-host disease following allogeneic bone marrow transplantation.
Champlin R; Gajewski J; Feig S; Giorgi J; Lyddane N; Lee K; Schmidt I; Winston D; Ho W; Reichert T
Transplant Proc; 1989 Feb; 21(1 Pt 3):2947-8. PubMed ID: 2495694
[No Abstract] [Full Text] [Related]
9. Graft versus host tolerance in dogs across one DLA-haplotype by depletion of CD6 positive cells.
Schumm M; Kolb HJ; Hahn J; Beisser K; Rieber P; Günther W; Büttner M; Wilmanns W; Thierfelder S
Prog Clin Biol Res; 1992; 377():419-25. PubMed ID: 1438440
[No Abstract] [Full Text] [Related]
10. T-cell depletion in unrelated bone marrow transplantation.
Tricot G
Semin Hematol; 1992 Apr; 29(2 Suppl 1):26-31; discussion 31-2. PubMed ID: 1615342
[No Abstract] [Full Text] [Related]
11. Retention of graft-versus-leukemia using selective depletion of CD8-positive T lymphocytes for prevention of graft-versus-host disease following bone marrow transplantation for chronic myelogenous leukemia.
Champlin R; Jansen J; Ho W; Gajewski J; Nimer S; Lee K; Territo M; Winston D; Tricot G; Reichert T
Transplant Proc; 1991 Feb; 23(1 Pt 2):1695-6. PubMed ID: 1899162
[No Abstract] [Full Text] [Related]
12. A new marrow T cell depletion method using anti-CD6 monoclonal antibody-conjugated magnetic beads and its clinical application for prevention of acute graft-vs.-host disease in allogeneic bone marrow transplantation: results of a phase I-II trial.
Sao H; Kitaori K; Kasai M; Shimokawa T; Kato C; Yamanishi H; Ueda R; Morishima Y
Int J Hematol; 1999 Jan; 69(1):27-35. PubMed ID: 10641440
[TBL] [Abstract][Full Text] [Related]
13. Low-dose donor CD8+ cells in the CD4-depleted graft prevent allogeneic marrow graft rejection and severe graft-versus-host disease for chronic myeloid leukemia patients in first chronic phase.
Gallardo D; García-López J; Sureda A; Canals C; Ferra C; Cancelas JA; Berlanga JJ; Brunet S; Boqué C; Picón M; Torrico C; Amill B; Martino R; Martínez C; Martín-Henao G; Domingo-Albós A; Grañena A
Bone Marrow Transplant; 1997 Dec; 20(11):945-52. PubMed ID: 9422473
[TBL] [Abstract][Full Text] [Related]
14. Graft-versus-leukemia without graft-versus-host disease: an elusive goal of bone marrow transplantation.
Champlin R
Semin Hematol; 1992 Jul; 29(3 Suppl 2):46-52. PubMed ID: 1509294
[No Abstract] [Full Text] [Related]
15. [Ex-vivo treatment of a bone marrow graft].
Bieva CJ
Rev Med Brux; 1992 May; 13(5):177-82. PubMed ID: 1609193
[TBL] [Abstract][Full Text] [Related]
16. Selective T cell depletion with CD8-conjugated magnetic beads in the prevention of graft-versus-host disease after allogeneic bone marrow transplantation.
Jansen J; Hanks S; Akard L; Martin M; Thompson J; Chang Q; Ash R; Garrett P; Figg F; English D
Bone Marrow Transplant; 1995 Feb; 15(2):271-8. PubMed ID: 7773217
[TBL] [Abstract][Full Text] [Related]
17. Contribution of CD4+ and CD8+ T cells to graft-versus-host disease and graft-versus-leukemia reactivity after transplantation of MHC-compatible bone marrow.
Truitt RL; Atasoylu AA
Bone Marrow Transplant; 1991 Jul; 8(1):51-8. PubMed ID: 1833016
[TBL] [Abstract][Full Text] [Related]
18. Immunomagnetic purging in autologous bone marrow transplantation: experience in fourteen patients.
Canals C; Puntí C; Picón M; Amill B; Tugues D; Sanchez T; Badell I; Pardo N; Ortega J; Vivancos P
Prog Clin Biol Res; 1992; 377():289-96. PubMed ID: 1438427
[No Abstract] [Full Text] [Related]
19. T-cell depletion and allogeneic bone marrow transplantation.
O'Reilly RJ
Semin Hematol; 1992 Apr; 29(2 Suppl 1):20-6. PubMed ID: 1615341
[No Abstract] [Full Text] [Related]
20. Campath-1M antibodies for T cell depletion of haploidentical marrow transplanted to children with malignant osteopetrosis.
Fasth A; Porras O; Baltorano A; Carrillo J; Gonzales L; Odio C; de los Angeles Umaña M
Prog Clin Biol Res; 1992; 377():399-403. PubMed ID: 1438436
[No Abstract] [Full Text] [Related]
[Next] [New Search]
